Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nanocurcumin gel is an investigational nanoparticle formulation of curcumin being developed by Ain Shams University for endodontic applications. It is specifically designed as an intracanal medicament to treat periapical lesions in patients undergoing root canal retreatment. By reducing curcumin particles to the nanoscale (typically 10-100 nm), the formulation aims to overcome the poor solubility and low bioavailability of regular curcumin, enhancing its therapeutic efficacy. The drug exerts antimicrobial and anti-inflammatory effects to eliminate persistent endodontic infections and promote the healing of periapical tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nanocurcumin gel.